You're contacting media contact of this press release

Title: ActionCareHealth Highlights CoreAge Rx NAD+ Nasal Therapy as a Modern Solution for Cellular Energy, Cognitive Support, and Healthy Aging

Wichita Falls, TX, United States, 8th May 2026 - ActionCareHealth has published a new feature exploring the growing role of NAD+ nasal spray in supporting cellular energy, cognitive performance, and healthy aging, while presenting the NAD+ Nasal protocol from CoreAge Rx as a leading solution within the evolving longevity and wellness landscape.The article examines how modern wellness strategies are increasingly shifting toward therapies that address health at the cellular level rather than focusing only on surface-level outcomes. Among these emerging approaches, NAD+ nasal delivery has attracted growing interest for its targeted support of brain function, metabolic efficiency, and overall vitality.At the center of this approach is Nicotinamide Adenine Dinucleotide, commonly known as NAD+, a coenzyme naturally present in every cell of the body. NAD+ plays a critical role in cellular energy production, mitochondrial performance, DNA repair, and metabolic regulation. According to the feature published by ActionCareHealth, declining NAD+ levels are commonly associated with reduced energy, diminished cognitive clarity, slower recovery, and broader age-related cellular inefficiencies.The article highlights how the NAD+ Nasal protocol offered by CoreAge Rx is designed to support these foundational biological processes through a fast-acting intranasal delivery method that bypasses the digestive system and provides more direct access to the bloodstream and brain.Unlike traditional oral supplementation, the nasal spray delivery mechanism is intended to improve absorption efficiency while supporting more rapid systemic and neurological effects. The article notes that this intranasal approach aligns with growing demand for wellness therapies that prioritize precision, con...

This press release is issued by King Newswire